#METABOLOMICS WORKBENCH Lu_Group_20220325_181827 DATATRACK_ID:3141 STUDY_ID:ST002131 ANALYSIS_ID:AN003486 PROJECT_ID:PR001349
VERSION             	1
CREATED_ON             	April 6, 2022, 7:20 pm
#PROJECT
PR:PROJECT_TITLE                 	Discovery and characterization of virulence associated functional metabolites in
PR:PROJECT_TITLE                 	Escherichia coli based on functional metabolomics strategy
PR:PROJECT_SUMMARY               	Discovery and characterization of virulence associated functional metabolites in
PR:PROJECT_SUMMARY               	Escherichia coli based on functional metabolomics strategy
PR:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
PR:LAST_NAME                     	Lu
PR:FIRST_NAME                    	Haitao
PR:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
PR:EMAIL                         	haitao.lu@sjtu.edu.cn
PR:PHONE                         	15221478139
#STUDY
ST:STUDY_TITLE                   	Discovery and characterization of virulence associated functional metabolites in
ST:STUDY_TITLE                   	Escherichia coli based on functional metabolomics strategy(pellets
ST:STUDY_TITLE                   	metabolomics-2)
ST:STUDY_SUMMARY                 	Bacterial metabolites are substrates of virulence factors of uropathogenic
ST:STUDY_SUMMARY                 	Escherichia coli (UPEC), but the mechanism underlying the role of functional
ST:STUDY_SUMMARY                 	metabolites in bacterial virulence from the perspective of small molecular
ST:STUDY_SUMMARY                 	metabolism is unclear. In the present study, we used a strategy of functional
ST:STUDY_SUMMARY                 	metabolomics integrated with bacterial genetics in attempt to decipher the
ST:STUDY_SUMMARY                 	mechanism of virulence formation in Escherichia coli (E. coli) from the
ST:STUDY_SUMMARY                 	viewpoint of small molecule metabolism. We identified the virulence-associated
ST:STUDY_SUMMARY                 	metabolome via analysis of the primary metabolome of the pathogenic UTI89 strain
ST:STUDY_SUMMARY                 	and the non-pathogenic MG1655 strain. Then, the iron-mediated virulence
ST:STUDY_SUMMARY                 	associated metabolome was identified by an iron fishing strategy. Also, the
ST:STUDY_SUMMARY                 	mechanism of siderophores in regulating pathogenicity in different environments
ST:STUDY_SUMMARY                 	was explored by investigating the effect of iron on siderophore biosynthesis.
ST:STUDY_SUMMARY                 	Finally, by knocking out genes related to siderophore biosynthesis, siderophore
ST:STUDY_SUMMARY                 	transport and iron utilization, siderophores dependent iron-regulating virulence
ST:STUDY_SUMMARY                 	associated metabolome, including 18 functional metabolites, was identified and
ST:STUDY_SUMMARY                 	verified to be involved in the regulation of bacterial virulence. Based on this
ST:STUDY_SUMMARY                 	we found that these functional metabolites regulated the virulence of E. coli by
ST:STUDY_SUMMARY                 	targeting multiple metabolic pathways in an iron-siderophores dependent manner.
ST:STUDY_SUMMARY                 	Moreover, a quantitative proteomics approach was implemented to further
ST:STUDY_SUMMARY                 	elucidate the mechanism of functional metabolites and functional proteins in
ST:STUDY_SUMMARY                 	modulating bacterial virulence. And our findings demonstrated that functional
ST:STUDY_SUMMARY                 	proteins regulated the virulence of E. coli by mediating iron binding,
ST:STUDY_SUMMARY                 	iron-siderophore transmembrane transport, and the biosynthesis and expression of
ST:STUDY_SUMMARY                 	functional metabolites. Interestingly, we found that functional metabolites
ST:STUDY_SUMMARY                 	enhance the virulence of E. coli by specifically modulating the key metabolic
ST:STUDY_SUMMARY                 	pathways involved in purine metabolism, proline metabolism, arginine metabolism
ST:STUDY_SUMMARY                 	and pyrimidine metabolism. Taken together, our study identified for the first
ST:STUDY_SUMMARY                 	time 18 functional metabolites regulating the of E. coli virulence, greatly
ST:STUDY_SUMMARY                 	enriching our understanding of the mechanism of functional metabolites that
ST:STUDY_SUMMARY                 	regulate the E. coli virulence by targeting primary metabolism, which will
ST:STUDY_SUMMARY                 	largely contribute to the development of new strategies to target
ST:STUDY_SUMMARY                 	virulence-based diagnosis and therapy of infections caused by different
ST:STUDY_SUMMARY                 	pathogens.
ST:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
ST:LAST_NAME                     	Lu
ST:FIRST_NAME                    	Haitao
ST:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
ST:EMAIL                         	haitao.lu@sjtu.edu.cn
ST:PHONE                         	15221478139
#SUBJECT
SU:SUBJECT_TYPE                  	Bacteria
SU:SUBJECT_SPECIES               	Escherichia coli
SU:TAXONOMY_ID                   	562
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-1P
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-2P
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-3P
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-4P
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-5P
SUBJECT_SAMPLE_FACTORS           	-	ybtP-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtP-0-6P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-1P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-2P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-3P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-4P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-5P
SUBJECT_SAMPLE_FACTORS           	-	ybtQ-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtQ-0-6P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-1P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-2P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-3P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-4P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-5P
SUBJECT_SAMPLE_FACTORS           	-	fyuA-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=fyuA-0-6P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-1P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-1P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-2P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-2P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-3P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-3P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-4P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-4P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-5P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-5P
SUBJECT_SAMPLE_FACTORS           	-	fur-0-6P	Treatment:No iron supplementation	RAW_FILE_NAME=fur-0-6P
#COLLECTION
CO:COLLECTION_SUMMARY            	After 18h of culture, the sample pellet was isolated. The bacterial pellets
CO:COLLECTION_SUMMARY            	harvested from 50 mL of broth culture were mixed with 1.2 mL 80% ice-cold
CO:COLLECTION_SUMMARY            	methanol (added to internal standard 0.001mg/ml 4-chloro-DL-phenylalanine), then
CO:COLLECTION_SUMMARY            	vortexed for 30 s, and placed on dry ice for 30 min. The samples were
CO:COLLECTION_SUMMARY            	centrifuged at 18000 × g for 15 min at 4 °C. The frozen samples were ground
CO:COLLECTION_SUMMARY            	with beads and the homogenates were centrifuged at 18000 × g for 15 min at 4
CO:COLLECTION_SUMMARY            	°C. The supernatant was mixed with 800μL ice-cold acetonitrile, and then left
CO:COLLECTION_SUMMARY            	to stand for 20 minutes in an ice bath. After centrifugation at 18000 × g 4℃
CO:COLLECTION_SUMMARY            	for 15 min, the supernatant was removed and filtered through 0.22μm membrane.
CO:SAMPLE_TYPE                   	Bacterial cells
#TREATMENT
TR:TREATMENT_SUMMARY             	M63 medium (1.36% monopotassium phosphate, 0.2% ammonium sulfate, 0.024%
TR:TREATMENT_SUMMARY             	magnesium sulfate, 0.001% calcium chloride, and 0.0015% nicotinic acid) was used
TR:TREATMENT_SUMMARY             	to form UTI89 mutants. The E. coli strain was incubated in LB-agar plate for 12
TR:TREATMENT_SUMMARY             	hours, one colony was isolated to LB broth for further 4 hours incubation, then
TR:TREATMENT_SUMMARY             	diluted the solution into M63 medium at a ratio of 1:100 and the cultures were
TR:TREATMENT_SUMMARY             	incubated for another18 h at 37°C, 200rpm to culture E. coli.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The bacterial pellets harvested from 50 mL of broth culture were mixed with 1.2
SP:SAMPLEPREP_SUMMARY            	mL 80% ice-cold methanol (added to internal standard 0.001mg/ml
SP:SAMPLEPREP_SUMMARY            	4-chloro-DLphenylalanine), then vortexed for 30 s, and placed on dry ice for 30
SP:SAMPLEPREP_SUMMARY            	min. The samples were centrifuged at 18000 × g for 15 min at 4 °C. The frozen
SP:SAMPLEPREP_SUMMARY            	samples were ground with beads and the homogenates were centrifuged at 18000 ×
SP:SAMPLEPREP_SUMMARY            	g for 15 min at 4 °C. The supernatant was mixed with 800μL ice-cold
SP:SAMPLEPREP_SUMMARY            	acetonitrile, and then left to stand for 20 minutes in an ice bath. After
SP:SAMPLEPREP_SUMMARY            	centrifugation at 18000 × g 4℃ for 15 min, the supernatant was removed and
SP:SAMPLEPREP_SUMMARY            	filtered through 0.22μm membrane. For LC/MS based metabolomics analysis, the
SP:SAMPLEPREP_SUMMARY            	dried samples were dissolved in 200μL water and 5μL aliquots were analyzed.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Waters Acquity BEH HSS T3 (100 x 2.1mm, 1.8um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6495 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Agilent MassHunter Workstation Data Acquisition Agilent MassHunter
MS:MS_COMMENTS                   	QualitativeAnalysis B.07.00 Agilent MassHunter Quantitative Analysis (for QQQ)
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak area
MS_METABOLITE_DATA_START
Samples	fur-0-1P	fur-0-2P	fur-0-3P	fur-0-4P	fur-0-5P	fur-0-6P	fyuA-0-1P	fyuA-0-2P	fyuA-0-3P	fyuA-0-4P	fyuA-0-5P	fyuA-0-6P	ybtP-0-1P	ybtP-0-2P	ybtP-0-3P	ybtP-0-4P	ybtP-0-5P	ybtP-0-6P	ybtQ-0-1P	ybtQ-0-2P	ybtQ-0-3P	ybtQ-0-4P	ybtQ-0-5P	ybtQ-0-6P
Factors	Treatment:No iron supplementation	Treatment:No iron supplementation	Treatment:No iron supplementation	Treatment:No iron supplementation	Treatment:No iron supplementation	Treatment:No iron supplementation	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions
Maleic acid	15.9888602	10.6455	22.7941552	17.972349	15.1550762	17.7595815	14.2305403	9.68080604	13.2228563	17.1743368	16.5044588	18.082273	10.1544922	12.5304594	24.5010523	15.7868923	24.1704099	19.9642533	402.785405	564.075294	371.211952	281.825191	382.249361	552.245621
Taurine	436.08945	316.809189	406.636411	533.951569	352.605143	397.951067	297.974509	239.986029	339.137436	303.827054	331.914074	341.430717	472.988246	630.551694	735.504194	555.283967	702.082692	650.610956	486.74169	410.530261	505.113837	469.830055	691.057993	814.682857
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Molecular weight	RT (min)	m/z
Maleic acid	116.07	1.1	133
Taurine	125.15	0.9	126
METABOLITES_END
#END